| Oct 30 |
Investors might be losing patience for Crinetics Pharmaceuticals' (NASDAQ:CRNX) increasing losses, as stock sheds 5.6% over the past week
|
| Oct 17 |
State Street Corp's Strategic Acquisition in Crinetics Pharmaceuticals
|
| Oct 16 |
Crinetics Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 12, 2024
|
| Oct 10 |
Crinetics Pharmaceuticals Announces October 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
| Oct 10 |
Morning Movers: Arcadium Lithium surges after deal to be acquired
|
| Oct 9 |
Crinetics Pharmaceuticals Inc (CRNX) Q2 2024 Earnings Call Highlights: Strategic Advances Amid ...
|
| Oct 9 |
Crinetics Pharmaceuticals prices $500M equity at $50 per share
|
| Oct 9 |
Crinetics Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock
|
| Oct 8 |
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
|
| Sep 26 |
Crinetics Submits New Drug Application for Paltusotine for the Treatment of Acromegaly
|
